| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 10/14/2010 | WO2010118025A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group |
| 10/14/2010 | WO2010118023A1 Methods for the preparation of drospirenone |
| 10/14/2010 | US20100261167 In vivo screen using chemical inducers of dimerization |
| 10/13/2010 | EP2238147A2 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 10/13/2010 | CN101861328A Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/13/2010 | CN101861327A An amorphous form of an anti-inflammatory compound |
| 09/30/2010 | US20100249082 Modulators of hypoxia inducible factor-1 and related uses |
| 09/29/2010 | EP1771462B1 A process for the preparation of 7-alpha-alkylated 19-norsteroids |
| 09/23/2010 | WO2010106383A1 Novel crystalline form of antiprogestin cdb-4124 |
| 09/23/2010 | US20100240684 Minoxidil aqueous composition containing bile acid |
| 09/21/2010 | US7799770 For use in female birth control, for therapy of hormone-dependent gynecological disorders and for hormone replacement therapy |
| 09/16/2010 | WO2010102673A1 Hellebrin and hellebrigenin derivatives |
| 09/08/2010 | CN101822657A Pachysandra terminalis alkaloid compound for resisting tumor metastasis |
| 09/01/2010 | CN101817860A Synthetic method of 13C marked glycocholic acid |
| 08/31/2010 | CA2364493C Nitrate esters and their use for neurological conditions |
| 08/25/2010 | EP2219587A1 Sterol-modified amphiphilic lipids |
| 08/19/2010 | WO2010092381A1 Process for the preparation of cholyl-l-lysine |
| 08/19/2010 | CA2752309A1 Process for the preparation of cholyl-l-lysine |
| 08/11/2010 | CN101798332A Cholic acid coupling compound, preparation method and application thereof |
| 08/10/2010 | US7772220 Methods and compositions for reducing toxicity of a pharmaceutical compound |
| 08/10/2010 | US7772218 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |
| 08/10/2010 | US7772003 Lipid derivatives of aminoglycosides |
| 08/10/2010 | CA2419801C Steroid derived antibiotics |
| 08/10/2010 | CA2250309C Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 08/05/2010 | US20100197647 Compounds that inhibit oestrone sulphatase; compositions thereof; and methods employing the same |
| 08/04/2010 | EP2212279A1 Cationic lipids |
| 07/28/2010 | EP2209795A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 07/28/2010 | CN101790509A Process for preparing estrogen-antagonistic 11 ss-fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-alkylamino-omega-perfluoroalkyl)alkyl side chain and a-alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation |
| 07/27/2010 | US7763600 Nitric ester derivatives of hormones such as progesterone, used for preventing premature labor, increasing cervical dilatation, in hormone replacement therapy, as hypeortensive agents and for treating dysmenorrhea |
| 07/27/2010 | US7763596 Antiinflamamtory agents; immunosuppressants; antiproliferative agents; treating haematology; reduced harmful side-effects |
| 07/27/2010 | CA2444266C Use of bile acid or bile salt fatty acid conjugates |
| 07/27/2010 | CA2427569C Selective glucocorticoid receptor agonists |
| 07/20/2010 | US7759330 21-substituted progesterone derivatives as new antiprogestational agents |
| 07/14/2010 | EP2205620A2 An amorphous form of an anti-inflammatory compound |
| 07/07/2010 | EP2203173A2 Means and methods for counteracting muscle disorders |
| 07/06/2010 | US7750185 Photoactive materials |
| 06/30/2010 | EP2202240A1 Compound |
| 06/24/2010 | WO2010071772A2 Synthesis of 3b-amino-5-cholestene and related 3b-halides involving i-steroid and retro-i-steroid rearrangements |
| 06/24/2010 | US20100160657 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 06/24/2010 | US20100160268 Isoflavonoid Analogs and their Metal Conjugates as Anti-Cancer Agents |
| 06/22/2010 | CA2586538C Nitroxy steroids |
| 06/22/2010 | CA2479991C Process for production of crystals, crystals obtained thereby and their use in pharmaceutical preparations |
| 06/22/2010 | CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens |
| 06/01/2010 | US7728157 Oxidizing only a primary hydroxy on a fused ring to form an aldehyde, leaving the secondary OH alone; sulfating with pyridine:SO3 the primary OH on a fused ring leaving the secondary OH alone. |
| 06/01/2010 | US7727976 achieving prolonged therapeutic or prophylactic blood concentrations of a drug or active metabolite ; transportating through intestine walls |
| 05/27/2010 | WO2010059853A1 Tgr5 modulators and method of use thereof |
| 05/27/2010 | CA2744189A1 Tgr5 modulators and methods of use thereof |
| 05/26/2010 | EP2188301A2 Novel steroidal esters of 17-oximino-5-androsten-3 beta-ol |
| 05/26/2010 | EP2188299A2 A method for treating diabetes |
| 05/11/2010 | CA2294709C Compositions and methods for enhancing delivery of therapeutic agents to cells |
| 05/06/2010 | US20100113408 21-substituted progesterone derivatives as new antiprogestational agents |
| 04/28/2010 | EP2178899A1 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 04/22/2010 | WO2010043506A1 Method and intermediates for preparing 2-alkoxy and 2-aryloxy estrogen compounds |
| 04/22/2010 | WO2010012904A3 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 04/15/2010 | WO2009146218A3 Compounds including an anti-inflammatory pharmacore and methods of use |
| 04/13/2010 | US7696247 Lipid-based nitric oxide donors |
| 04/07/2010 | EP2170925A2 17ß -CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 03/31/2010 | EP2167525A2 17ß-CYANO-19-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 03/25/2010 | US20100075314 Chemically-modified gold nanoparticles and methods for use in detecting target molecules |
| 03/24/2010 | CN101679479A 17ss-cyano-19-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679478A 17ss-cyano-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679477A 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 03/24/2010 | CN101679476A 23-substituted bile acids as TGR5 modulators and methods of use thereof |
| 03/24/2010 | CN101676363A Liquid crystal aligning agent, liquid crystal display element and compound |
| 03/18/2010 | US20100069654 Process for the preparation of tauroursodesoxycholic acid |
| 03/18/2010 | US20100069627 Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 03/11/2010 | US20100062055 Lipid-based nitric oxide donors |
| 03/11/2010 | US20100062023 Cholesterol-containing compounds and their use as immunogens against borrelia burgdorferi |
| 03/10/2010 | EP2160398A2 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11ß-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS |
| 03/09/2010 | CA2425572C Process and intermediates for the production of 7-substituted antiestrogens |
| 03/04/2010 | US20100056767 Selective separation or extraction of steroidal glycosides by supercritical fluid extraction using carbon dioxide |
| 03/04/2010 | US20100056488 Corticosteroid conjugates and uses thereof |
| 02/25/2010 | WO2009146218A8 Compounds including an anti-inflammatory pharmacore and methods of use |
| 02/23/2010 | US7666846 a conjugate of chloesterol containing compound having a sugar moiety containing methyl esteralkyleneazide group and a carrier protein; produce an effective vaccine to prevent Lyme disease |
| 02/18/2010 | WO2009144738A4 Medicinal applications of benzoic acid hydrazones synthesized on the basis of steroidal tigogenin |
| 02/17/2010 | CN101652380A nitric oxide releasing steroids |
| 02/11/2010 | WO2010015875A1 Process for the preparation of lanosta-8-ene compou |
| 02/11/2010 | WO2010015529A1 New no releasing steroids derivatives |
| 02/11/2010 | US20100036115 Novel Compositions for the Delivery of Negatively Charged Molecules |
| 02/11/2010 | CA2731477A1 New no releasing steroids derivatives |
| 02/09/2010 | CA2625906C Lazaroids-based compositions and methods for preventing adhesion formation using the same |
| 02/09/2010 | CA2403756C Structural modification of 19-norprogesterone i: 17-.alpha.-substituted, 11-.beta.-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 02/04/2010 | WO2010012904A2 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 02/04/2010 | WO2010012567A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/04/2010 | US20100029906 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 02/04/2010 | CA2731513A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 02/04/2010 | CA2725791A1 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method_______________________ |
| 01/27/2010 | EP2147014A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 01/27/2010 | EP1343485B1 Drug delivery system comprising a lipid-based nitric oxide donor |
| 01/26/2010 | CA2505575C 17alpha-hydroxy-14beta-steroids with hormonal effect |
| 01/26/2010 | CA2435010C A process for the preparation of 3-glutamido bile ester derivatives using n-protected methyl pyroglutamate |
| 01/26/2010 | CA2427632C Process for the production of 4-(17.alpha.-substituted-3-oxoestra-4,9-dien-11.beta.-yl)benzaldehyde-(1e or 1z)-oximes |
| 01/13/2010 | EP1594884B1 Antitumoral 18a-homoestra-1,3,5(10)-trien-3-yl 2-substituted sulfamates |
| 01/12/2010 | CA2468412C 17.alpha.-alkyl-17.beta.-oxy-estratrienes and intermediates for their production, use of the 17.alpha.-alkyl-17.beta.-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparations |
| 01/05/2010 | US7641914 Acid-sensitive compounds, their preparation and uses |
| 12/30/2009 | EP2137206A1 Process for the preparation of tauroursodesoxycholic acid |
| 12/30/2009 | CN101616926A Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 12/17/2009 | US20090312299 Isolated Isomers of Norelgestromin and Methods of Making and Using the Same |
| 12/10/2009 | WO2009122435A3 Simultaneous preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine |
| 12/03/2009 | WO2009146218A2 Compounds including an anti-inflammatory pharmacore and methods of use |